1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow PrEP-001 6.4 mg: new trials by email Literature Review of PrEP-001 6.4 mg trials Research Report on PrEP-001 6.4 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety Study to Compare the Effect of Two PrEP-001 Nasal Powder Formulations on Nasal Mucosa and Serum Cytokine Production PrEP-001 6.4 mg, PrEP-001 3.2 mg, Placebo - Upper Respiratory Tract Infections | Phase 1 | Completed | Prep Biopharm Limited | 20 | 2017-05-08 | 2017-07-02 |
Respiratory Tract Infections (1)
United Kingdom (1)